DexCom Net Interest Income from 2010 to 2026

DC4 Stock  EUR 61.93  0.59  0.96%   
DexCom's Net Interest Income is increasing over the last several years with slightly volatile swings. Net Interest Income is estimated to finish at about 99.1 M this year. Net Interest Income is the difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities. View All Fundamentals
 
Net Interest Income  
First Reported
2019-03-31
Previous Quarter
28 M
Current Value
19.3 M
Quarterly Volatility
21.6 M
 
Covid
 
Interest Hikes
Check DexCom financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among DexCom's main balance sheet or income statement drivers, such as Interest Expense of 31.7 M, Selling General Administrative of 742.9 M or Total Revenue of 4.9 B, as well as many indicators such as . DexCom financial statements analysis is a perfect complement when working with DexCom Valuation or Volatility modules.
  
This module can also supplement various DexCom Technical models . Check out the analysis of DexCom Correlation against competitors.
The Net Interest Income trend for DexCom Inc offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether DexCom is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest DexCom's Net Interest Income Growth Pattern

Below is the plot of the Net Interest Income of DexCom Inc over the last few years. It is the difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities. DexCom's Net Interest Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in DexCom's overall financial position and show how it may be relating to other accounts over time.
Net Interest Income10 Years Trend
Slightly volatile
   Net Interest Income   
       Timeline  

DexCom Net Interest Income Regression Statistics

Arithmetic Mean11,065,882
Coefficient Of Variation551.08
Mean Deviation44,606,644
Median(300,000)
Standard Deviation60,981,627
Sample Variance3718.8T
Range215.5M
R-Value0.46
Mean Square Error3129.1T
R-Squared0.21
Significance0.06
Slope5,549,167
Total Sum of Squares59500.1T

DexCom Net Interest Income History

202699.1 M
202594.4 M
2024115.2 M
2023114.7 M
2022-600 K
2021-100.3 M
2020-68.6 M

About DexCom Financial Statements

DexCom stakeholders use historical fundamental indicators, such as DexCom's Net Interest Income, to determine how well the company is positioned to perform in the future. Although DexCom investors may analyze each financial statement separately, they are all interrelated. For example, changes in DexCom's assets and liabilities are reflected in the revenues and expenses on DexCom's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in DexCom Inc. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Interest Income94.4 M99.1 M

Currently Active Assets on Macroaxis

When determining whether DexCom Inc is a strong investment it is important to analyze DexCom's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact DexCom's future performance. For an informed investment choice regarding DexCom Stock, refer to the following important reports:
Check out the analysis of DexCom Correlation against competitors.
You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
It's important to distinguish between DexCom's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding DexCom should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, DexCom's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.